Pradeep Neupane

Dr. Pradeep Neupane


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
PNPradeep Neupane
Pradeep Neupane
RMRicardo G Maggi
Ricardo G Maggi
MBManoj Basnet
Manoj Basnet
ELErin Lashnits
Erin Lashnits
GAGerard P. Andrews
Gerard P. Andrews
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
Bartonella spp. comprise a genus of Gram-negative alphaproteobacteria that are slow growing, fastidious, and facultative intracellular pathogens with zoonotic potential. Immunofluorescent antibody assays (IFAs), Western blot (WB), and enzyme-linked immunosorbent assays (ELISAs), the frequently used modalities for the serological diagnosis of canine and human Bartonelloses, generate numerous false negative results. Therefore, the development of a reliable serodiagnostic assay for Bartonelloses is of clinical and epidemiological importance. Pap31, a heme binding surface protein of B. henselae, is associated with bacterial adhesion and related to bacterial colonization. To our knowledge, B. henselae Pap31 and its fragments (N-terminal (NTD), middle (MD), and C-terminal (CTD) domains) have not been investigated for the serodiagnosis of canine and human Bartonelloses. In this study, we evaluate the diagnostic utility of B. henselae recombinant whole Pap31 (rPap31) and Pap31 fragments by ELISA using sera from 70 dogs (36 Bartonella spp. IFA-positive (naturally infected), and 34 Bartonella spp. IFA- and PCR-negative (control dogs)) and 36 humans (18 Bartonella spp. IFA-positive (naturally infected) and 18 controls)). In the dogs, the area under the curve (AUC) score of recombinant whole Pap31 was 0.714 with a sensitivity of 42% and specificity of 94% at an OD cutoff value of 0.8955. Among the evaluated recombinant Pap31 proteins for the diagnosis of canine Bartonelloses, rPap31-NTD yielded the highest AUC score of 0.792 (95% CI 0.688–0.895) with a sensitivity of 44% and specificity of 100% at a cutoff value of 1.198. In concordance with this finding, rPap31-NTD also had the highest AUC score of 0.747 (95% CI 0.581–0.913) among the Pap31 recombinant proteins for the diagnosis of human Bartonelloses, with 39% sensitivity and 94% specificity at a cutoff value of 1.366. Recombinant whole Pap31 (rPap31) resulted in 72% sensitivity and 61% specificity at a cutoff value of 0.215 for human Bartonelloses. Due to either low sensitivity or questionable specificity, our findings indicate that recombinant Pap31 and the selected fragments may not be appropriate diagnostic targets in detecting anti-Bartonella antibodies in Bartonella-infected dogs and humans. The findings from this study can be used to further assess the antigenicity and immunogenicity of B. henselae Pap31 as a diagnostic target.

26 April 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
ELErin Lashnits
Erin Lashnits
CRCynthia Robveille
Cynthia Robveille
PNPradeep Neupane
Pradeep Neupane
TRToni Richardson
Toni Richardson
KLKeith Linder
Keith Linder
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
Bartonella henselae is an important zoonotic pathogen with a wide range of clinical manifestations in humans. Despite advances in understanding its pathogenesis, there is no broadly applicable laboratory animal model for bartonellosis. This study aimed to assess the potential utility of an experimental model of chronic B. henselae infection using ferrets, a species previously utilized in various human pathogen studies. Six ferrets (n = 6) were divided into three groups: a control group (n = 2), a low-dose infection group (n = 2), and a high-dose infection group (n = 2). The two infection groups were inoculated intradermally with 105 (low dose) and 109 (high dose) CFU/mL B. henselae, respectively. Clinical signs, serological responses, and bacteriological findings were monitored over seven weeks; ferrets were then euthanized and tissues were examined histologically. Only minimal or transient systemic clinical signs and laboratory abnormalities developed in B. henselae inoculated ferrets. The high-dose group seroconverted to B. henselae antigen within two weeks, maintaining elevated titers throughout the study. Histopathological examination revealed that four B. henselae-infected ferrets had notable microscopic inflammatory lesions in the liver parenchyma (3/4), heart (1/4), and brain (1/4); similar lesions were not observed in the tissues of the two control ferrets. Despite the presence of microscopic lesions and seroconversion in the high-dose group, bacteremia was not documented and B. henselae DNA was not successfully amplified by quantitative PCR from lesional organs. This pilot study demonstrated that ferrets may serve as a promising model for investigating B. henselae pathogenesis, diagnosis, treatment, and prevention.

7 November 2026 in Animals
Verified
Journal Article
Open access
PDF file
PNPradeep Neupane
Pradeep Neupane
JBJessika Bryant
Jessika Bryant
EKEmily Marie Kingston
Emily Marie Kingston
RMRicardo G Maggi
Ricardo G Maggi
MAMarcos André
Marcos André
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
Bartonella species are small, fastidious, Gram-negative intracellular bacteria that are capable of infecting a wide range of mammals, including cats, dogs and humans. Diagnoses of canine, feline, and human bartonellosis by culture, molecular, and serological assays remains challenging. Accurate serodiagnosis of feline bartonellosis is of clinical, epidemiological and zoonotic importance. The utility of Bartonella henselae (Bh) ATP-β, ATP synthase beta subunit, and GroEL, a chaperonin protein, has not previously been reported for diagnosis of feline bartonellosis. The objective of this study was to assess the diagnostic utility of Bh recombinant proteins ATP-β and GroEL using sera samples from Group I: four cats experimentally inoculated with Bh or saline (n = 24); Group II: 34 cats naturally infected with Bh (n = 34); Group III: 33 Bartonella spp. qPCR-negative and IFA-negative control cats (n = 33), and Group IV: 16 Mycoplasma haemofelis qPCR-positive cats (n = 16). Based on the Bh rATP-β, rGroEL, and rATP-β plus rGroEL ELISA results, rGroEL yielded the highest area under the receiver operating characteristic curve (AUC) of 0.84 (95% CI 0.74–0.94), followed by rATP-β plus rGroEL with an AUC of 0.77 (95% CI 0.65–0.89). The sensitivity and specificity of rGroEL were 50% (95% CI 34–66%) and 91% (95% CI 76–97%), respectively, at an OD cutoff value of 0.1, whereas the sensitivity and specificity of rATP-β plus rGroEL ELISA (combination of rATP-β and rGroEL) were 71% (95% CI 54–83%) and 85% (95% CI 69–93%), respectively, at an OD cutoff value of 0.17. Overall agreement between Bh IFA and rGroEL-based ELISA was 70% (95% CI 58–80%), and overall agreement between Bh IFA and rATP-β plus rGroEL-based ELISA was 78% (95% CI 66–86%). The rATP-β-based ELISA had a poorer AUC (0.61 (95% CI 0.47–0.75)), indicating limited clinical utility for the serodiagnosis of Bh infection in cats. These findings suggest that rGroEL and rATP-β plus rGroEL may serve as reliable ELISA antigens for serodiagnosis of Bartonella infection in cats. Limitations of this study include the small sample size, the moderate sensitivity of ELISA, and its incomplete agreement with Bh IFA and PCR results. Future epitope mapping and bioinformatic screening of the antigenic regions of rATP-β and rGroEL may facilitate the development of a faster, more practical, and more cost-effective alternative to the labor-intensive reference IFA for the serodiagnosis of feline bartonellosis.